Waldemar Priebe Selected Research

Tumor Viral Antigens (Large T Antigen)

5/2017

Novel Molecular Multilevel Targeted Antitumor Agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Waldemar Priebe Research Topics

Disease

51	Neoplasms (Cancer) 09/2023 - 12/2002
11	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 10/2007
11	Melanoma (Melanoma, Malignant) 12/2018 - 01/2004
9	Glioma (Gliomas) 01/2022 - 01/2010
7	Breast Neoplasms (Breast Cancer) 12/2018 - 07/2002
4	Neoplasm Metastasis (Metastasis) 12/2018 - 07/2002
4	Brain Neoplasms (Brain Tumor) 12/2018 - 07/2009
4	Carcinoma (Carcinomatosis) 04/2015 - 05/2005
3	Necrosis 04/2015 - 01/2006
3	Carcinogenesis 01/2013 - 12/2008
3	Hypoxia (Hypoxemia) 01/2011 - 12/2002
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2007 - 05/2005
2	Cardiotoxicity 01/2023 - 05/2007
2	COVID-19 10/2021 - 08/2021
2	Infections 10/2021 - 08/2021
2	Ovarian Neoplasms (Ovarian Cancer) 10/2019 - 10/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018 - 01/2004
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2017 - 12/2016
2	Prostatic Neoplasms (Prostate Cancer) 04/2015 - 01/2011
2	Leukemia 12/2011 - 04/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2011 - 01/2009
2	Squamous Cell Carcinoma of Head and Neck 07/2011 - 01/2009
2	Hematologic Neoplasms (Hematological Malignancy) 12/2007 - 03/2007
2	Lung Neoplasms (Lung Cancer) 10/2007 - 01/2004
2	Polyploidy 01/2006 - 02/2003
2	Osteosarcoma (Osteogenic Sarcoma) 01/2004 - 12/2002
1	Liver Diseases (Liver Disease) 02/2023
1	Sarcoma (Soft Tissue Sarcoma) 01/2023
1	Disease Progression 01/2022
1	Adenocarcinoma 10/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019

Drug/Important Bio-Agent (IBA)

15	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 07/2002
11	AnthracyclinesIBA 01/2023 - 01/2004
11	WP1066IBA 01/2022 - 12/2007
8	Proteins (Proteins, Gene)FDA Link 12/2018 - 01/2006
8	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2012 - 12/2008
7	WP 631IBA 04/2015 - 04/2002
5	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 03/2007
5	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2023 - 05/2005
5	annamycinIBA 01/2023 - 07/2002
5	CytokinesIBA 12/2014 - 05/2005
5	Deoxyglucose (2 Deoxy D glucose)IBA 07/2011 - 12/2002
4	Glucose (Dextrose)FDA LinkGeneric 04/2021 - 12/2006
3	EnzymesIBA 01/2022 - 12/2018
3	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 05/2005
3	degrasynIBA 01/2014 - 04/2007
3	Janus KinasesIBA 01/2014 - 02/2008
3	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 06/2012 - 02/2008
3	WP 1193IBA 05/2012 - 01/2010
3	Phosphotransferases (Kinase)IBA 09/2011 - 12/2007
2	Cytotoxins (Cytolysins)IBA 11/2021 - 12/2014
2	Antiviral Agents (Antivirals)IBA 10/2021 - 08/2021
2	MicroRNAs (MicroRNA)IBA 10/2021 - 08/2021
2	Phosphopyruvate Hydratase (Enolase)IBA 01/2021 - 12/2020
2	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2017 - 04/2007
2	WP760IBA 10/2017 - 10/2007
2	LigandsIBA 05/2017 - 01/2017
2	Insulin (Novolin)FDA Link 01/2017 - 09/2011
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2016 - 04/2009
2	epidermal growth factor receptor VIIIIBA 12/2014 - 01/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014 - 12/2007
2	Interleukin-6 (Interleukin 6)IBA 01/2014 - 01/2010
2	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 09/2012 - 12/2010
2	Janus Kinase 2IBA 05/2012 - 04/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2011 - 01/2004
2	Transcription Factors (Transcription Factor)IBA 12/2007 - 01/2005
2	multidrug resistance-associated protein 1IBA 04/2007 - 04/2007
2	Cisplatin (Platino)FDA LinkGeneric 07/2003 - 01/2003
1	ProdrugsIBA 09/2023
1	EstersIBA 09/2023
1	EsterasesIBA 09/2023
1	CollagenIBA 02/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Chelating AgentsIBA 01/2023
1	IronIBA 01/2023
1	Cytostatic AgentsIBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	Angiotensin II Type 1 Receptor BlockersIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023
1	Mineralocorticoid Receptor AntagonistsIBA 01/2023
1	HexokinaseIBA 01/2022
1	Butyric Acid (Butanoic Acid)IBA 11/2021
1	Histone Deacetylase InhibitorsIBA 11/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 11/2021
1	Mannose (D-Mannose)IBA 04/2021
1	Eph Family Receptors (Eph Receptors)IBA 04/2020
1	AntigensIBA 04/2020
1	Therapeutic UsesIBA 01/2020
1	Contrast MediaIBA 10/2019
1	3,6-di-O-acetyl-2-deoxy-D-glucopyranoseIBA 10/2019
1	Pyruvic Acid (Pyruvate)IBA 10/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2019
1	CarbonIBA 10/2019

Therapy/Procedure

19	Therapeutics 01/2023 - 12/2002
4	Drug Therapy (Chemotherapy) 12/2018 - 01/2010
3	Radiotherapy 01/2022 - 01/2010
3	Immunotherapy 05/2010 - 10/2007
2	Aftercare (After-Treatment) 10/2019 - 07/2002